Breast cancer is classified into four molecular subtypes—luminal A, luminal B, HER2-positive, and triple-negative breast cancer (TNBC)—each with distinct characteristics, prognosis, and treatment strategies. The gene discussed is ERBB2; the disease is breast carcinoma.